Fangning Wan相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

FOXA1-dependent NSUN2 facilitates the advancement of prostate cancer by preserving TRIM28 mRNA stability in a m5C-dependent manner

FOXA1依赖的NSUN2通过m5C依赖的方式维持TRIM28 mRNA的稳定性，从而促进前列腺癌的进展。

期刊:npj Precision Oncology

影响因子:6.8

doi:10.1038/s41698-025-00904-x

Zhenda Wang #,Abudurexiti Mierxiati #,Wenkai Zhu,Tian Li,Hua Xu,Fangning Wan,Dingwei Ye

发表日期：2025

文献求助收藏

IKBKE regulates renal cell carcinoma progression and sunitinib resistance through the RRM2-AKT pathway

IKBKE 通过 RRM2-AKT 通路调控肾细胞癌的进展和舒尼替尼耐药性。

期刊:International Journal of Biological Sciences

影响因子:8.2

doi:10.7150/ijbs.102666

Shiwei Liu,Junhong Li,Junyu Zhang,Fangning Wan,Zongyuan Hong,Zhe Hong,Bo Dai

细胞生物学

发表日期：2024

文献求助收藏

Lysine methyltransferase SMYD2 enhances androgen receptor signaling to modulate CRPC cell resistance to enzalutamide

赖氨酸甲基转移酶 SMYD2 增强雄激素受体信号传导，从而调节 CRPC 细胞对恩杂鲁胺的耐药性

期刊:Oncogene

影响因子:6.9

doi:10.1038/s41388-024-02945-1

Junhong Li #, Zhe Hong #, Junyu Zhang, Shengfeng Zheng, Fangning Wan, Zheng Liu, Bo Dai

细胞生物学

发表日期：2024

文献求助收藏

Targeting SMYD2 inhibits prostate cancer cell growth by regulating c-Myc signaling

靶向 SMYD2 通过调节 c-Myc 信号抑制前列腺癌细胞生长

期刊:Molecular Carcinogenesis

doi:10.1002/mc.23536

Junhong Li, Fangning Wan, Junyu Zhang, Shengfeng Zheng, Yunjie Yang, Zhe Hong, Bo Dai

发表日期：2023

文献求助收藏

Positive epigenetic regulation loop between AR and NSUN2 promotes prostate cancer progression

AR 和 NSUN2 之间的正向表观遗传调控环路促进前列腺癌进展

期刊:Clinical and Translational Medicine

影响因子:7.9

doi:10.1002/ctm2.1028

Wenkai Zhu, Fangning Wan, Wenhao Xu, Zheng Liu, Junjie Wang, Hena Zhang, Shenglin Huang, Dingwei Ye

发表日期：2022

文献求助收藏

Fatty Acid Synthase Correlates With Prognosis-Related Abdominal Adipose Distribution and Metabolic Disorders of Clear Cell Renal Cell Carcinoma

脂肪酸合酶与透明细胞肾细胞癌预后相关的腹部脂肪分布和代谢紊乱相关

期刊:Frontiers in Molecular Biosciences

影响因子:3.9

doi:10.3389/fmolb.2020.610229

Wenhao Xu, Xiaoxin Hu, Aihetaimujiang Anwaier, Jun Wang, Wangrui Liu, Xi Tian, Wenkai Zhu, Chunguang Ma, Fangning Wan, Guohai Shi, Yuan-Yuan Qu, Hailiang Zhang, Dingwei Ye

发表日期：2021

文献求助收藏

m6A Regulator-Mediated Methylation Modification Model Predicts Prognosis, Tumor Microenvironment Characterizations and Response to Immunotherapies of Clear Cell Renal Cell Carcinoma

m6A 调节器介导的甲基化修饰模型可预测透明细胞肾细胞癌的预后、肿瘤微环境特征和对免疫疗法的反应

期刊:Frontiers in Oncology

影响因子:3.5

doi:10.3389/fonc.2021.709579

Wenhao Xu, Xi Tian, Wangrui Liu, Aihetaimujiang Anwaier, Jiaqi Su, Wenkai Zhu, Fangning Wan, Guohai Shi, Gaomeng Wei, Yuanyuan Qu, Hailiang Zhang, Dingwei Ye

发表日期：2021

文献求助收藏

Targeting CPT1B as a potential therapeutic strategy in castration-resistant and enzalutamide-resistant prostate cancer

以 CPT1B 为靶点作为去势抵抗性和恩杂鲁胺抵抗性前列腺癌的潜在治疗策略

期刊:Prostate

影响因子:2.6

doi:10.1002/pros.24027

Mierxiati Abudurexiti, Wenkai Zhu, Yuchen Wang, Jun Wang, Wenhao Xu, Yongqiang Huang, Yao Zhu, Guohai Shi, Hailiang Zhang, Yiping Zhu, Yijun Shen, Bo Dai, Fangning Wan, Guowen Lin, Dingwei Ye

发表日期：2020

文献求助收藏

Identification of tumor-infiltrating immune cells and prognostic validation of tumor-infiltrating mast cells in adrenocortical carcinoma: results from bioinformatics and real-world data

肾上腺皮质癌中肿瘤浸润免疫细胞的鉴定和肿瘤浸润肥大细胞的预后验证：来自生物信息学和真实世界数据的结果

期刊:Oncoimmunology

doi:10.1080/2162402X.2020.1784529

Xi Tian, Wenhao Xu, Yuchen Wang, Aihetaimujiang Anwaier, Hongkai Wang, Fangning Wan, Yu Zhu, Dalong Cao, Guohai Shi, Yiping Zhu, Yuanyuan Qu, Hailiang Zhang, Dingwei Ye

发表日期：2020

文献求助收藏

AMPK Promotes SPOP-Mediated NANOG Degradation to Regulate Prostate Cancer Cell Stemness

AMPK 促进 SPOP 介导的 NANOG 降解以调节前列腺癌细胞干性

期刊:Developmental Cell

影响因子:10.7

doi:10.1016/j.devcel.2018.11.033

Xinbo Wang, Jiali Jin, Fangning Wan, Linlin Zhao, Hongshang Chu, Cong Chen, Guanghong Liao, Jian Liu, Yue Yu, Hongqi Teng, Lan Fang, Cong Jiang, Weijuan Pan, Xin Xie, Jia Li, Xiaolin Lu, Xuejun Jiang, Xin Ge, Dingwei Ye, Ping Wang

发表日期：2019

文献求助收藏